The transient nature of the Th17 phenotype

European Journal of Immunology

Volumn 40, Issue 12, 2010, Pages 3312-3316

  Annunziato, Francesco ^a   Romagnani, Sergio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

RORC; T bet; Th cells

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL POPULATION; EFFECTOR CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY B; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH1-TH2 BALANCE; TH17 CELLS;

EID: 78649544524     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201041145     Document Type: Article

References (36)

1. Mosmann, T. R., Cherwinski, C., Bond, M. W., Giedlin, M. A. and Coffman, R. L., Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986. 136: 2348-2357.
2. Romagnani, S., Human TH1 and TH2 subsets: doubt no more. Immunol. Today 1991. 12: 256-257.
3. Romagnani, S., The Th1/Th2 paradigm. Immunol. Today. 1997. 18: 263-266.
4. Annunziato, F., Cosmi, L., Manetti, R., Brugnolo, F., Parronchi, P., Maggi, E., Nagata, K. and Romagnani, S., Reversal of human allergen-specific CRTH2+T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide. J. Allergy Clin. Immunol. 2001. 108: 815-821.
5. Hegazy, A. N., Peine, M., Helmstetter, C., Panse, I., Fröhlich, A., Bergthaler, A., Flatz, L. et al., Interferons direct Th2 cell reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined Th2 and Th1 cell functions. Immunity 2010. 32: 116-128.
6. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744-748.
7. Dubin, P. J. and Kolls, J. K., Th17 cytokines and mucosal immunity. Immunol. Rev. 2008. 226: 160-171.
8. Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D. and Cua, D. J., Divergent pro- and anti-inflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 1951-1958.
9. McGeachy, M. J., Chen, Y., Tato, C. M., Laurence, A., Joyce-Shaikh, B., Blumenschein, W. M., McClanahan, T. K. et al., The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 2009. 10: 314-324.
10. Tato, C. M., Laurence, A. and O'Shea, J. J., Helper T cell differentiation enters a new era: le roi est mort; vive le roi. J. Exp. Med. 2006. 203: 809-812.
11. Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231-234.
12. Veldhoen, M., Hocking, R. J., Atkinsm, C. J., Locksley, R. M. and Stockinger, B., TGF-beta in the context of an inflammatory cytokine milieu supports differentiation of IL-17-producing T cells. Immunity 2006. 25: 179-189.
13. Huber, M., Brüstle, A., Reinhard, K., Guralnik, A., Walter, G., Mahiny, A., von Löw, E. and Lohoff M., IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 2008. 105: 20846-20851.
14. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 1849-1861.
15. Cosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., Querci, V. et al., Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 2010. 125: 222-230.
16. +TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010. 207: 2479-2491.
17. +T cell precursor. J. Exp. Med. 2008. 205: 1903-1916.
18. Kleinschek, M. A., Boniface, K., Sadekova, S., Grein, J., Murphy, E. E., Turner, S. P., Raskin, L. et al., Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation. J. Exp. Med. 2009. 206: 525-534.
19. Santarlasci, V., Maggi, L., Capone, M., Frosali, F., Querci, V., De Palma, R., Liotta, F. et al., TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 2009. 39: 207-215.
20. Marks, B. R., Nowyhed, H. N., Choi, J. Y., Poholek, A. C., Odegard, J. M., Flavell, R. A. and Craft, J., Thymic selfreactivity selects natural interleukin 17-producing T cells that can regulate peripheral inflammation. Nat. Immunol. 2009. 10: 1125-1132.
21. Das, J., Ren, G., Zhang, L., Roberts, A. I., Zhao, X., Bothwell, A. L., Van Kaer, L. et al., Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J. Exp. Med. 2009. 206: 2407-2416.
22. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C., A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 2006. 203: 1685-1691.
23. Annunziato, F. and Romagnani, S., Do studies in humans better depict Th17 cells? Blood 2009. 114: 2213-2219.
24. Doodes, P. D., Cao, Y., Hamel, K. M., Wang, Y., Farkas, B., Iwakura, Y. and Finnegan, A., Development of proteoglycan-induced arthritis is independent of IL-17. J. Immunol. 2008. 181: 329-337.
25. Luger, D., Silver, P. B., Tang, J., Cua, D., Chen, Z., Iwakura, Y., Bowman, E. P. et al., Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008. 205: 799-810.
26. Kroenke, M. A., Chensue, S. W. and Segal, B. M., EAE mediated by a non-IFN-γ/non-IL-17 pathway. Eur. J. Immunol. 2010. 40: 2340-2348.
27. Annunziato, F., Cosmi, L., Liotta, F., Maggi, E., Romagnani, S., Human Th17 cells: are they different from murine Th17 cells? Eur. J. Immunol. 2009. 39: 637-640.
28. Lee, Y. K., Turner, H., Maynard, C. L., Oliver, J. R., Chen, D., Elson, C. O. and Weaver, C. T., Late developmental plasticity in the T helper 17 lineage. Immunity. 2009. 30: 92-107.
29. Wei, G., Wei, L., Zhu, J., Zang, C., Hu-Li, J., Yao, Z., Cui, K. et al., Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+T cells. Immunity 2009. 30: 155-167.
30. Mukasa, R., Balasubramani, A., Lee, Y. K., Whitley, S. K., Weaver, B. T., Shibata, Y., Crawford, G. E. et al., Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010. 32: 616-627.
31. Lexberg, M. H., Taubner, A., Albrecht, I., Lepenies, I., Richter, A., Kamradt, T., Radbruch, A. and Chang, H. D., IFN-γ and IL-12 synergize to convert in vivo-generated Th17 into Th1/17 cells. Eur. J. Immunol. 2010; in press.
32. Martin-Orozco, N., Chung, Y., Chang, S. H., Wang, Y. H. and Dong, C., Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 2009. 39: 216-224.
33. Bending, D., De La Peña, H., Veldhoen, M., Phillips, J. M., Uyttenhove, C., Stockinger, B. and Cooke, A., Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 2009 Feb 2. pii: 37865. doi: 10.1172/JCI37865. [Epub ahead of print]
34. Nistala, K., Adams, S., Cambrook, H., Ursu, S., Olivito, B., de Jager, W., Evans, J. G. et al., Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc. Natl. Acad. Sci. USA 2010. 107: 14751-14756.
35. Kurschus, F. C., Croxford, A. L., Heinen, A. P., Wörtge, S., Ielo, D. and Waisman, A., Genetic proof for the transient nature of the Th17 phenotype. Eur. J. Immunol. 2010. 40: 3336-3346.
36. Gottlieb, A., Menter, A., Mendelsohn, A., Shen, Y. K., Li, S., Guzzo, C., Fretzin, S. et al., Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial. Lancet 2009. 373: 633-640.